Page last updated: 2024-10-29

staurosporine aglycone and Ovarian Neoplasms

staurosporine aglycone has been researched along with Ovarian Neoplasms in 1 studies

staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor

Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

Research Excerpts

ExcerptRelevanceReference
"MTT assays showed that the ovarian cancer cell line SK-OV-3 cells were sensitive to the growth inhibitory effect of K252a."1.33K252a inhibits proliferation of ovarian cancer cells by upregulating p21WAF1. ( Fukuda, J; Miyakawa, I; Nasu, K; Nishida, M; Takai, N; Ueda, T, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takai, N1
Ueda, T1
Nishida, M1
Nasu, K1
Fukuda, J1
Miyakawa, I1

Other Studies

1 other study available for staurosporine aglycone and Ovarian Neoplasms

ArticleYear
K252a inhibits proliferation of ovarian cancer cells by upregulating p21WAF1.
    Oncology reports, 2005, Volume: 14, Issue:1

    Topics: Blotting, Western; Carbazoles; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation

2005